ECSP066631A - Variantes de inmunoglobulinas y uso de las mismas - Google Patents

Variantes de inmunoglobulinas y uso de las mismas

Info

Publication number
ECSP066631A
ECSP066631A ECSP066631A ECSP066631A EC SP066631 A ECSP066631 A EC SP066631A EC SP066631 A ECSP066631 A EC SP066631A EC SP066631 A ECSP066631 A EC SP066631A
Authority
EC
Ecuador
Prior art keywords
immunoglobulins
variations
same
malignant
antibodies
Prior art date
Application number
Other languages
English (en)
Inventor
Camellia W Adams
Andrew C Chan
Craig W Crowley
Henry B Lowman
Gerald R Nakamura
Leonard G Presta
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ECSP066631A publication Critical patent/ECSP066631A/es

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención proporciona anticuerpos humanizados y quiméricos anti-CD20 para el tratamiento de enfermedades malignas y autoinmunes positivas para CD20.
ECSP066631 2003-12-01 2006-06-09 Variantes de inmunoglobulinas y uso de las mismas ECSP066631A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52616303P 2003-12-01 2003-12-01

Publications (1)

Publication Number Publication Date
ECSP066631A true ECSP066631A (es) 2006-10-25

Family

ID=40433445

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP066631 ECSP066631A (es) 2003-12-01 2006-06-09 Variantes de inmunoglobulinas y uso de las mismas

Country Status (1)

Country Link
EC (1) ECSP066631A (es)

Similar Documents

Publication Publication Date Title
HRP20050649B1 (hr) Varijante imunoglobulina i njihovo korištenje
DOP2006000029A (es) Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas)
TNSN06133A1 (en) Immunoglobulin variants and uses thereof
DK1613347T3 (da) Humaniserede antistoffer, der genkender beta-amyloidpeptid
HRP20181459T1 (hr) Humanizirani antagonisti anti-beta7 i njihove uporabe
CY2012019I1 (el) Ανθρωπινα μονοκλωνα αντισωματα εναντια στο cd20
MY176959A (en) Humanized antibodies that recognize beta amyloid peptide
MX2025000260A (es) Proteina de union al antigeno anti-steap1
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
ITMI20031127A1 (it) Anticorpi anti-hgf-r e loro uso
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
CR9562A (es) Anticuerpos anti-cd40 humanizados y sus metodos de uso
UY29283A1 (es) Anticuerpos ab(beta)usados en mejorar la cognicion
PE20091193A1 (es) Proteinas humanas de union a antigenos del gm-csf
EA202191769A1 (ru) Тубулизины и конъюгаты белок-тубулизин
EA201891499A1 (ru) Химерное собачье анти-cd20 антитело
ECSP066631A (es) Variantes de inmunoglobulinas y uso de las mismas